Israel Discount Bank of New York’s AtriCure ATRC Stock Holding History

Israel Discount Bank of New York’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-310	Closed	-$8K	–	108
2019 Q1	$8K	Hold	310	–	–	0.01%	383
2018 Q4	$9K	Buy	+310	New	+$9.66K	0.01%	377

Other funds holding ATRC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Israel Discount Bank of New York's ATRC Position: Q2 2019 in Review

Israel Discount Bank of New York sold out of AtriCure (ATRC) in Q2 2019, closing a stake of 310 shares — an estimated $8K sold.

Israel Discount Bank of New York first reported a position in ATRC in Q4 2018 and held it in 2 quarters. The position peaked at $9K in Q4 2018. 145 funds tracked by Wall St. Rank hold ATRC as of Q2 2019.

Israel Discount Bank of New York reported no remaining AtriCure position as of Q2 2019 after selling out during the quarter.
Israel Discount Bank of New York sold 310 AtriCure shares in Q2 2019, an estimated $8K.
Israel Discount Bank of New York first reported a position in AtriCure in Q4 2018 and held it in 2 quarters.
Israel Discount Bank of New York's AtriCure position peaked at $9K in Q4 2018.
145 funds tracked by Wall St. Rank held AtriCure as of Q2 2019.

Based on Israel Discount Bank of New York's 13F filing for Q2 2019, filed 14 Aug 2019.